FDA issues notice to Hospira over medical device issues

02/14/2013 | Reuters

Hospira said it has received a notice from the FDA over certain quality concerns involving its medical devices. CEO F. Michael Ball said that while inspectors noted progress had been made, "there is still a lot of work to be done within our device operations."

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC